Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients With Sepsis*

1 Service of Endocrinology and Nutrition, University Hospital Doctor Peset, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), Valencia, Spain 2 CIBERehd—Department of Pharmacology University of Valencia, Valencia, Spain 3 Department of Physiology, University of Valencia, Valencia, Spain *See also p. 935. Drs. Vezza and Victor disclosed that this study was financed by grants PI19/00838, PI19/0437 and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CB06/04/0071 from the Carlos III Health Institute, by the Ministry of Education of the Valencian Regional Government (PROMETEO/2019/027), and by the European Regional Development Fund (“A way to build Europe”), that they are recipients of contracts CES/10/030 and CD19/00180 from the Ministry of Health of the Valencian Regional Government and Carlos III Health Institute, and work for hire.